Biomaterial Database

[Effect of amitryptyline drops, in ambulatory therapy, on behavior and character disorders in children and adolescents]. 1969

C Sallou

UI	MeSH Term	Description	Entries
D008297	Male		Males
D009497	Neurotic Disorders	Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.	Neuroses,Psychoneuroses,Disorder, Neurotic,Disorders, Neurotic,Neurotic Disorder
D011596	Psychomotor Disorders	Abnormalities of motor function that are associated with organic and non-organic cognitive disorders.	Psychomotor Impairment,Developmental Psychomotor Disorders,Psychomotor Disorders, Developmental,Developmental Psychomotor Disorder,Impairment, Psychomotor,Impairments, Psychomotor,Psychomotor Disorder, Developmental,Psychomotor Impairments
D002605	Character	In current usage, approximately equivalent to personality. The sum of the relatively fixed personality traits and habitual modes of response of an individual.	Characters
D002648	Child	A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.	Children
D002653	Child Behavior Disorders	Disturbances considered to be pathological based on age and stage appropriateness, e.g., conduct disturbances and anaclitic depression. This concept does not include psychoneuroses, psychoses, or personality disorders with fixed patterns.	Childhood Behavior Disorders,Behavior Disorder, Child,Behavior Disorder, Childhood,Child Behavior Disorder,Childhood Behavior Disorder,Disorder, Childhood Behavior
D002675	Child, Preschool	A child between the ages of 2 and 5.	Children, Preschool,Preschool Child,Preschool Children
D004361	Drug Tolerance	Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL.	Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D004775	Enuresis	Involuntary discharge of URINE after expected age of completed development of urinary control. This can happen during the daytime (DIURNAL ENURESIS) while one is awake or during sleep (NOCTURNAL ENURESIS). Enuresis can be in children or in adults (as persistent primary enuresis and secondary adult-onset enuresis).
D005260	Female		Females

Related Publications

C Sallou

[Character and behavior disorders in children and adolescents. Practical problems--therapeutic methods].

June 1962, Concours medical,

C Sallou

[Contribution to the study of the effect of propericiazine on character and behavior disorders observed in children and adolescents].

March 1969, Revue de neuropsychiatrie infantile et d'hygiene mentale de l'enfance,

C Sallou

[Effect of propericiazine on behavior disorders of children and adolescents].

June 1970, Laval medical,

C Sallou

[Medicinal therapy of behavior disorders in children & adolescents].

May 1959, Die Medizinische,

C Sallou

[EEG in character & behavior disorders of children].

January 1952, Schweizer Archiv fur Neurologie und Psychiatrie. Archives suisses de neurologie et de psychiatrie. Archivio svizzero di neurologia e psichiatria,

C Sallou

[Electroencephalogram in character and behavior disorders in children].

August 1952, Revue medicale de la Suisse romande,

C Sallou

[DIAGNOSTIC DIFFICULTIES IN CHARACTER DISORDERS IN CHILDREN AND ADOLESCENTS].

January 1965, Wiadomosci lekarskie (Warsaw, Poland : 1960),

C Sallou

CHARACTER AND BEHAVIOR DISORDERS.

July 1964, Military medicine,

C Sallou

[MAJEPTIL IN CHARACTER AND BEHAVIOR DISORDERS IN MENTALLY DEFICIENT CHILDREN].

March 1964, Laval medical,